| Date | Title | | | | 05/10/13 | Sunesis to Present at Upcoming Investor Conferences| SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.
Dan Swisher, Chief Executive Officer of Sunesis, will present at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14th at 3:00 PM Pacific Time at the Encore at the Wynn in Las Vegas.
Eric Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer ... |
|  |  | | 05/09/13 | Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights| Sunesis to Host Conference Call Today at 11:00AM Eastern Time
SOUTH SAN FRANCISCO, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the quarter ended March 31, 2013. Loss from operations for the three months ended March 31, 2013 was $7.8 million. As of March 31, 2013, cash, cash equivalents and marketable securities totaled $61.0 million.
"We continue to make great progress with the VALOR trial, which has now enrolled 6... |
| | | | 05/02/13 | Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights| SOUTH SAN FRANCISCO, Calif., May 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Thursday, May 9, 2013 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2013.
The call can be accessed by dialing (877) 280-4958 (U.S. and Canada) or (857) 244-7315 (international), and entering passcode 39516372.
To access the live audio webcast, or the subsequent ... |
| | | | 04/24/13 | Sunesis to Present at the Needham & Company 12th Annual Healthcare Conference| SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the Needham & Company 12th Annual Healthcare Conference on Wednesday, May 1, 2013 at 8:00 AM Eastern Time at the Westin Grand Central Hotel in New York City.
A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be a... |
| | | | 03/13/13 | Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights| Sunesis to Host Conference Call Today at 11:00AM Eastern Time
SOUTH SAN FRANCISCO, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the fourth quarter and year ended December 31, 2012. Loss from operations for the three months and year ended December 31, 2012 was $8.1 million and $34.6 million, respectively. As of December 31, 2012, cash, cash equivalents and marketable securities totaled $71.2 million.
"Last year wa... |
| | | | 03/11/13 | Sunesis to Present at the 25th Annual Roth Conference| SOUTH SAN FRANCISCO, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Adam R. Craig, M.D., Ph.D., Executive Vice President, Development and Chief Medical Officer of Sunesis, will be presenting at the 25th Annual Roth Conference on Tuesday, March 19, 2013 at 11:00 AM Pacific Time at The Ritz Carlton in Dana Point, CA.
A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the ... |
| | | | 03/06/13 | Sunesis to Host Conference Call on March 13th to Discuss Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights| SOUTH SAN FRANCISCO, Calif., March 6, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Wednesday, March 13th, 2013 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter and year ended December 31, 2012.
The call can be accessed by dialing (866) 383-8108 (U.S. and Canada) or (617) 597-5343 (international), and entering passcode 36968092.
To access the live audio webcast, or ... |
| | | | 02/20/13 | Sunesis to Present at Upcoming Investor Conferences| SOUTH SAN FRANCISCO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at two upcoming investor conferences:
RBC Capital Markets 2013 Global Healthcare Conference
Tuesday, February 26th at 8:00 AM Eastern Time
New York Palace Hotel, New York City
Cowen & Company 33rd Annual Health Care Conference
Tuesday, March 5th at 9:20 AM Eastern Time
The Boston Marriott Cop... |
| | | | 02/06/13 | Sunesis to Present at the Leerink Swann 2013 Global Healthcare Conference| SOUTH SAN FRANCISCO, Calif., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President, Corporate Development and Finance at Sunesis, will be presenting at the Leerink Swann 2013 Global Healthcare Conference on Wednesday, February 13, 2013 at 4:00 PM Eastern Time at The Waldorf Astoria in New York City.
A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay... |
| | | | 01/10/13 | Sunesis Announces Clinical Trial Updates and 2013 Milestones at the 31st Annual JP Morgan Healthcare Conference| VALOR Enrollment Reaches 500 Patients; Enrollment Doubles in LI-1 Trial
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, provided a corporate update, including a clinical trial enrollment update and overview of 2013 major corporate milestones, in a presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco. A webcast replay of the presentatio... |
| | | | 01/02/13 | Sunesis to Present at the J.P. Morgan Healthcare Conference| SOUTH SAN FRANCISCO, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 12:00 PM Pacific Time at the Westin St. Francis Hotel in San Francisco.
A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "C... |
| | |
|
